Antigen presentation

Antigen presentation stimulates T cells to become either "cytotoxic" CD8+ cells or "helper" CD4+ cells.

Antigen presentation is a vital immune process that is essential for T cell immune response triggering. Because T cells recognize only fragmented antigens displayed on cell surfaces, antigen processing must occur before the antigen fragment can be recognized by a T-cell receptor. Specifically, the fragment, bound to the major histocompatibility complex (MHC), is transported to the surface of the cell antigen-presenting cell, a process known as presentation. If there has been an infection with viruses or bacteria, the cell antigen-presenting cell will present an endogenous or exogenous peptide fragment derived from the antigen by MHC molecules. There are two types of MHC molecules which differ in the behaviour of the antigens: MHC class I molecules (MHC-I) bind peptides from the cell cytosol, while peptides generated in the endocytic vesicles after internalisation are bound to MHC class II (MHC-II).[1] Cellular membranes separate these two cellular environments - intracellular and extracellular. Each T cell can only recognize tens to hundreds of copies of a unique sequence of a single peptide among thousands of other peptides presented on the same cell, because an MHC molecule in one cell can bind to quite a large range of peptides.[2][3] Predicting which (fragments of) antigens will be presented to the immune system by a certain MHC/HLA type is difficult, but the technology involved is improving.[4]

  1. ^ Janeway Jr CA, Travers P, Walport M, Shlomchik MJ (2001-01-01). "Chapter 5 Antigen Presentation to T Lymphocytes". Immunobiology: The Immune System in Health and Disease. 5th edition. Garland Science.
  2. ^ Purcell AW, Croft NP, Tscharke DC (June 2016). "Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology!". Current Opinion in Immunology. 40: 88–95. doi:10.1016/j.coi.2016.03.007. PMID 27060633.
  3. ^ Janeway Jr CA, Travers P, Walport M, Shlomchik MJ (2001-01-01). "The major histocompatibility complex and its functions". Immunobiology: The Immune System in Health and Disease (5th ed.). Garland Science.
  4. ^ Bouzid R, de Beijer MT, Luijten RJ, Bezstarosti K, Kessler AL, Bruno MJ, Peppelenbosch MP, Demmers JA, Buschow SI (May 2021). "Empirical Evaluation of the Use of Computational HLA Binding as an Early Filter to the Mass Spectrometry-Based Epitope Discovery Workflow". Cancers. 13 (10): 2307. doi:10.3390/cancers13102307. PMC 8150281. PMID 34065814.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search